vs
Side-by-side financial comparison of Borr Drilling Ltd (BORR) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Borr Drilling Ltd is the larger business by last-quarter revenue ($267.7M vs $207.8M, roughly 1.3× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 13.1%, a 44.3% gap on every dollar of revenue.
Borr Drilling Ltd is a global offshore drilling contractor owning and operating a modern fleet of high-spec jack-up rigs. It offers drilling services to oil and gas exploration and production firms, with main operations across the North Sea, Southeast Asia, Middle East, and West Africa for shallow-water and marginal field projects.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BORR vs IDYA — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $267.7M | $207.8M |
| Net Profit | $35.1M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 36.0% | 52.2% |
| Net Margin | 13.1% | 57.4% |
| Revenue YoY | -1.5% | — |
| Net Profit YoY | 10.7% | 330.1% |
| EPS (diluted) | $0.14 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $207.8M | ||
| Q2 25 | $267.7M | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $271.9M | $0 | ||
| Q1 24 | — | $0 | ||
| Q2 23 | $187.5M | — | ||
| Q3 22 | — | $29.7M | ||
| Q2 22 | $105.3M | — |
| Q3 25 | — | $119.2M | ||
| Q2 25 | $35.1M | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | $31.7M | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q2 23 | $800.0K | — | ||
| Q3 22 | — | $1.6M | ||
| Q2 22 | $-165.3M | — |
| Q3 25 | — | 52.2% | ||
| Q2 25 | 36.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 38.4% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 31.9% | — | ||
| Q3 22 | — | 2.2% | ||
| Q2 22 | -116.8% | — |
| Q3 25 | — | 57.4% | ||
| Q2 25 | 13.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 0.4% | — | ||
| Q3 22 | — | 5.4% | ||
| Q2 22 | -157.0% | — |
| Q3 25 | — | $1.33 | ||
| Q2 25 | $0.14 | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | $0.12 | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q2 23 | $0.00 | — | ||
| Q3 22 | — | $0.04 | ||
| Q2 22 | $-1.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $92.4M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.0B | $1.1B |
| Total Assets | $3.4B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | $92.4M | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | $195.3M | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q2 23 | $83.8M | — | ||
| Q3 22 | — | $386.2M | ||
| Q2 22 | $29.7M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | $281.8M | — |
| Q3 25 | — | $1.1B | ||
| Q2 25 | $1.0B | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $999.2M | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q2 23 | $906.2M | — | ||
| Q3 22 | — | $368.8M | ||
| Q2 22 | $711.5M | — |
| Q3 25 | — | $1.2B | ||
| Q2 25 | $3.4B | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $3.2B | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q2 23 | $3.0B | — | ||
| Q3 22 | — | $410.9M | ||
| Q2 22 | $3.0B | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 0.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.3M | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 0.18× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $142.2M | ||
| Q2 25 | $6.3M | — | ||
| Q3 24 | — | $-49.2M | ||
| Q2 24 | $16.0M | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q2 23 | $2.4M | — | ||
| Q3 22 | — | $-24.2M | ||
| Q2 22 | $-8.5M | — |
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q2 23 | — | — | ||
| Q3 22 | — | $-25.3M | ||
| Q2 22 | — | — |
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | -85.1% | ||
| Q2 22 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | 3.7% | ||
| Q2 22 | — | — |
| Q3 25 | — | 1.19× | ||
| Q2 25 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 3.00× | — | ||
| Q3 22 | — | -14.96× | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BORR
| Transferred Over Time | $256.6M | 96% |
| Transferred At Point In Time | $11.1M | 4% |
IDYA
Segment breakdown not available.
